The trademark MEPI was filed by Mölnlycke Health Care AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on August 29, 2024, and received one opposition filed on November 14, 2024 by biosyn Arzneimittel GmbH on Likelihood of confusion. and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 14, 2024
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).